Q3 2025 Earnings Call Transcript November 19, 2025 Vivos Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center ...
A live webcast of the conference call can be accessed on Vivos’ website at https://vivos.com/investor-relations. An online archive of the webcast will be available at Vivos’ website for 30 days ...
Q3 2025 Management View CEO R. Huntsman described Q3 2025 as "a watershed quarter and an inflection point in the trajectory of our business," emphasizing the company's ability to monetize its ...
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild ...
LITTLETON, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development ...
In much the same way that they’re designed to expand wearers’ upper airways, Vivos Therapeutics’ slate of oral appliances have now expanded their FDA indications, too. Collectively known as the ...
Every time Melia publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Q3 2025 Earnings Call November 19, 2025 5:00 PM ESTCompany ParticipantsBradford Amman - CFO, Treasurer & SecretaryR.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback